CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Patent Landscape
CHAPTER 4: NIACINAMIDE MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Powder
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Powder Niacinamide Market by Type
4.2.4.1 Natural Market size and forecast, by region
4.2.4.2 Synthetic Market size and forecast, by region
4.3 Liquid
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Others
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: NIACINAMIDE MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Pharmaceutical
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Cosmeceutical
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Human Nutrition
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Online Pharmacies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Drug stores and Retail Pharmacies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: NIACINAMIDE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.2.1 North America Powder Niacinamide Market by Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by Distribution Channel
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by Distribution Channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by Distribution Channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by Distribution Channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.2.1 Europe Powder Niacinamide Market by Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by Distribution Channel
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by Distribution Channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by Distribution Channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by Distribution Channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by Distribution Channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by Distribution Channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.2.1 Asia-Pacific Powder Niacinamide Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by Distribution Channel
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by Distribution Channel
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by Distribution Channel
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by Distribution Channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by Distribution Channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by Distribution Channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.2.1 LAMEA Powder Niacinamide Market by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by Distribution Channel
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by Distribution Channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by Distribution Channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by Distribution Channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by Distribution Channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Brother Enterprises Holding Co., Ltd
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Evonik Industries AG
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Fagron Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Foodchem International
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Glossier
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Jubilant Life Sciences Limited
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Koninklijke DSM N.V
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Lasons India Pvt Ltd
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Lonza Group
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Merck KGAA
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Veer Chemie
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Vertellus
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
TABLE 1. GLOBAL NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 2. NIACINAMIDE MARKET, FOR POWDER, BY REGION, 2021-2031 ($MILLION)
TABLE 3. NIACINAMIDE MARKET FOR POWDER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. NIACINAMIDE MARKET, FOR NATURAL, BY REGION, 2021-2031 ($MILLION)
TABLE 6. NIACINAMIDE MARKET, FOR SYNTHETIC, BY REGION, 2021-2031 ($MILLION)
TABLE 7. NIACINAMIDE MARKET, FOR LIQUID, BY REGION, 2021-2031 ($MILLION)
TABLE 8. NIACINAMIDE MARKET FOR LIQUID, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. NIACINAMIDE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. NIACINAMIDE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. GLOBAL NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 12. NIACINAMIDE MARKET, FOR PHARMACEUTICAL, BY REGION, 2021-2031 ($MILLION)
TABLE 13. NIACINAMIDE MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. NIACINAMIDE MARKET, FOR COSMECEUTICAL, BY REGION, 2021-2031 ($MILLION)
TABLE 15. NIACINAMIDE MARKET FOR COSMECEUTICAL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. NIACINAMIDE MARKET, FOR HUMAN NUTRITION, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NIACINAMIDE MARKET FOR HUMAN NUTRITION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 19. NIACINAMIDE MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 20. NIACINAMIDE MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. NIACINAMIDE MARKET, FOR ONLINE PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 22. NIACINAMIDE MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. NIACINAMIDE MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 24. NIACINAMIDE MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. NIACINAMIDE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. U.S. NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 32. U.S. NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 33. U.S. NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 34. CANADA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. CANADA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 36. CANADA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 37. MEXICO NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 38. MEXICO NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 39. MEXICO NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 40. EUROPE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 41. EUROPE POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 42. EUROPE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 43. EUROPE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 44. EUROPE NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 45. GERMANY NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 46. GERMANY NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. GERMANY NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 48. FRANCE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 49. FRANCE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. FRANCE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 51. UK NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 52. UK NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. UK NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 54. ITALY NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 55. ITALY NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 56. ITALY NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 57. SPAIN NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. SPAIN NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. SPAIN NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 68. JAPAN NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 69. JAPAN NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. JAPAN NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 71. CHINA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 72. CHINA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 73. CHINA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 74. AUSTRALIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 75. AUSTRALIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 77. INDIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 78. INDIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. INDIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 80. SOUTH KOREA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 81. SOUTH KOREA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. REST OF ASIA-PACIFIC NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 86. LAMEA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 87. LAMEA POWDER NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 88. LAMEA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 89. LAMEA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 90. LAMEA NIACINAMIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 91. BRAZIL NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 92. BRAZIL NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 93. BRAZIL NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 94. SAUDI ARABIA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 95. SAUDI ARABIA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 96. SAUDI ARABIA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 97. SOUTH AFRICA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. SOUTH AFRICA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 99. SOUTH AFRICA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA NIACINAMIDE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA NIACINAMIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 102. REST OF LAMEA NIACINAMIDE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 103.BROTHER ENTERPRISES HOLDING CO., LTD: COMPANY SNAPSHOT
TABLE 104.BROTHER ENTERPRISES HOLDING CO., LTD: OPERATING SEGMENTS
TABLE 105.BROTHER ENTERPRISES HOLDING CO., LTD: PRODUCT PORTFOLIO
TABLE 106.BROTHER ENTERPRISES HOLDING CO., LTD: NET SALES,
TABLE 107.BROTHER ENTERPRISES HOLDING CO., LTD: KEY STRATERGIES
TABLE 108.EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
TABLE 109.EVONIK INDUSTRIES AG: OPERATING SEGMENTS
TABLE 110.EVONIK INDUSTRIES AG: PRODUCT PORTFOLIO
TABLE 111.EVONIK INDUSTRIES AG: NET SALES,
TABLE 112.EVONIK INDUSTRIES AG: KEY STRATERGIES
TABLE 113.FAGRON INC.: COMPANY SNAPSHOT
TABLE 114.FAGRON INC.: OPERATING SEGMENTS
TABLE 115.FAGRON INC.: PRODUCT PORTFOLIO
TABLE 116.FAGRON INC.: NET SALES,
TABLE 117.FAGRON INC.: KEY STRATERGIES
TABLE 118.FOODCHEM INTERNATIONAL: COMPANY SNAPSHOT
TABLE 119.FOODCHEM INTERNATIONAL: OPERATING SEGMENTS
TABLE 120.FOODCHEM INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 121.FOODCHEM INTERNATIONAL: NET SALES,
TABLE 122.FOODCHEM INTERNATIONAL: KEY STRATERGIES
TABLE 123.GLOSSIER: COMPANY SNAPSHOT
TABLE 124.GLOSSIER: OPERATING SEGMENTS
TABLE 125.GLOSSIER: PRODUCT PORTFOLIO
TABLE 126.GLOSSIER: NET SALES,
TABLE 127.GLOSSIER: KEY STRATERGIES
TABLE 128.JUBILANT LIFE SCIENCES LIMITED: COMPANY SNAPSHOT
TABLE 129.JUBILANT LIFE SCIENCES LIMITED: OPERATING SEGMENTS
TABLE 130.JUBILANT LIFE SCIENCES LIMITED: PRODUCT PORTFOLIO
TABLE 131.JUBILANT LIFE SCIENCES LIMITED: NET SALES,
TABLE 132.JUBILANT LIFE SCIENCES LIMITED: KEY STRATERGIES
TABLE 133.KONINKLIJKE DSM N.V: COMPANY SNAPSHOT
TABLE 134.KONINKLIJKE DSM N.V: OPERATING SEGMENTS
TABLE 135.KONINKLIJKE DSM N.V: PRODUCT PORTFOLIO
TABLE 136.KONINKLIJKE DSM N.V: NET SALES,
TABLE 137.KONINKLIJKE DSM N.V: KEY STRATERGIES
TABLE 138.LASONS INDIA PVT LTD: COMPANY SNAPSHOT
TABLE 139.LASONS INDIA PVT LTD: OPERATING SEGMENTS
TABLE 140.LASONS INDIA PVT LTD: PRODUCT PORTFOLIO
TABLE 141.LASONS INDIA PVT LTD: NET SALES,
TABLE 142.LASONS INDIA PVT LTD: KEY STRATERGIES
TABLE 143.LONZA GROUP: COMPANY SNAPSHOT
TABLE 144.LONZA GROUP: OPERATING SEGMENTS
TABLE 145.LONZA GROUP: PRODUCT PORTFOLIO
TABLE 146.LONZA GROUP: NET SALES,
TABLE 147.LONZA GROUP: KEY STRATERGIES
TABLE 148.MERCK KGAA: COMPANY SNAPSHOT
TABLE 149.MERCK KGAA: OPERATING SEGMENTS
TABLE 150.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 151.MERCK KGAA: NET SALES,
TABLE 152.MERCK KGAA: KEY STRATERGIES
TABLE 153.VEER CHEMIE: COMPANY SNAPSHOT
TABLE 154.VEER CHEMIE: OPERATING SEGMENTS
TABLE 155.VEER CHEMIE: PRODUCT PORTFOLIO
TABLE 156.VEER CHEMIE: NET SALES,
TABLE 157.VEER CHEMIE: KEY STRATERGIES
TABLE 158.VERTELLUS: COMPANY SNAPSHOT
TABLE 159.VERTELLUS: OPERATING SEGMENTS
TABLE 160.VERTELLUS: PRODUCT PORTFOLIO
TABLE 161.VERTELLUS: NET SALES,
TABLE 162.VERTELLUS: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
